Medical News

RSS

Complementary and alternative health practices show promise for management of pain

A variety of complementary and alternative health practices —including meditation and relaxation techniques, manual therapies such as massage and spinal manipulation, meditative exercise forms such as yoga, Tai Chi, and ancient health practices such as acupuncture—show promise for contributing to the management of pain according to research presented at the Annual Scientific Meeting of the American Pain Society, www.ampainsoc.org.

20 May 2011

AIDS mortality in China drops by nearly two thirds since 2002 when country began free treatment program

China's HIV/AIDS-related mortality has dropped from 39.3 per 100 person-years in 2002 to 14.2 in 2009, or 64 percent, since the nation began providing free antiretroviral therapy (ART) in 2002, according to a study conducted by researchers from the Chinese Center for Disease Control and Prevention and published online Wednesday in Lancet Infectious Diseases, the New York Times reports (McNeil, 5/18).

20 May 2011

Bayer, Onyx to present Nexavar-chemotherapy combination Phase 2b trial data in breast cancer at ASCO 2011

Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. today announced results from a Phase 2b trial evaluating Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic breast cancer previously treated with a bevacizumab-containing regimen, which showed that Nexavar was associated with statistically significant improvements in progression-free survival and time-to-progression.

20 May 2011

GIS discovery could help generate stem cells more efficiently for biomedical applications

A team of scientists from Genome Institute of Singapore (GIS) of the Agency for Science, Technology and Research (A*STAR) have shown how proteins involved in controlling genes work together to carry out their functions in stem cells and demonstrated for the very first time, how they can change interaction partners to make other types of cells.

20 May 2011

African LGBT advocates warn against cutting multilateral aid to Uganda

At a World Bank panel discussion in Washington, D.C., on homophobia in developing countries, LGBT advocates from Africa expressed concern that if multilateral development organizations cut aid to Uganda in protest of attempts to make homosexual acts crimes punishable by death, the human rights situation for them could worsen, the Washington Blade reports.

20 May 2011

Naltrexone improves clinical, inflammatory activity in Crohn's disease patients

Naltrexone reduced inflammation in Crohn's patients in a research study at Penn State College of Medicine.

20 May 2011

Free, online tool to track exercise-induced asthma

Running into breathing problems when you exercise? You may have exercise-induced bronchoconstriction (EIB), commonly referred to as exercise-induced asthma. The American College of Allergy, Asthma and Immunology (ACAAI) has developed a free, easy-to-use online tool to track your symptoms: MyEIBJournal.org.

20 May 2011

9/11 Health fund administrator chosen

The Justice Department on Wednesday chose a special master to administer a multibillion-dollar fund created to provide compensation to rescue workers and others sickened from exposure to toxic fumes, dust and smoke from ground zero after the 2001 terrorist attack.

20 May 2011

VBL to present positive VB-111 preclinical data in metastatic lung cancer at 14th ASGCT

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present preclinical data demonstrating VB-111's potential synergy and additive therapeutic effect when administered in combination with the conventional chemotherapy cancer treatments.

20 May 2011

Tornier announces launch of Porous Coated Affiniti Stem for shoulder joint replacement surgery

Tornier Inc. the operating subsidiary of Tornier N.V., a leading global medical device company focused on serving extremities specialists who treat orthopedic conditions of the shoulder, elbow, wrist, hand, ankle and foot, today announced the introduction of the Porous Coated Affiniti Stem for shoulder joint replacement surgery.

20 May 2011

Study: Costs get in way of cancer patients refilling their prescriptions

About 10 percent of cancer patients aren't taking the oral medicines they need either because of the cost or they feel they are already taking too many other drugs, according to a study released by health-care consulting company Avalere Health late Wednesday.

20 May 2011

HealthGrades identifies major flaws in hospital ratings study

The findings of a journal article published in the May issue of the Archives of Surgery are fundamentally flawed and could undermine patients ability to find high quality hospital care, according to HealthGrades. The article, Evaluating Popular Media and Internet-Based Hospital Quality Ratings for Cancer Surgery, compared outcomes for gastrointestinal cancer patients who underwent surgery at hospitals on HealthGrades' "America's 50 Best Hospitals" and US News and World Report's "America's Best Hospitals" lists.

20 May 2011

Lilly's cixutumumab Phase II study results in five subtypes of sarcoma to be presented at 47th ASCO

Eli Lilly and Company announced data from its Phase II study with cixutumumab in five subtypes of sarcoma, a cancer that develops from connective tissues in the body.

20 May 2011

Longer looks: Tough health care questions for GOP presidential contenders; Robotics help spike use of prostate treatment

For my money, the most interesting thing about Mitt Romney's health-care speech last week wasn't his struggle to defend Romneycare and distance it from Obamacare, but the largely hostile reception of the speech from the right.

20 May 2011

$Positive results from Onyx's carfilzomib Phase 2b 003-A1 study in relapsed and refractory multiple myeloma$

Positive results from Onyx's carfilzomib Phase 2b 003-A1 study in relapsed and refractory multiple myeloma

Onyx Pharmaceuticals, Inc. today announced updated results from the Phase 2b 003-A1 study of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and refractory multiple myeloma. Carfilzomib achieved a clinical benefit rate (CBR) (minimal response or greater) in the study population of 37 percent with a duration of response (DOR) of 8.3 months.

20 May 2011

ViroPharma commences VP 20621 Phase 2 study for prevention of recurrent Clostridium difficile infection

ViroPharma Incorporated today announced initiation of a Phase 2 dose-ranging clinical study to evaluate the safety, tolerability, and efficacy of VP 20621 for prevention of recurrence of Clostridium difficile infection (CDI) in adults previously treated for CDI.

20 May 2011

CEL-SCI initiates global Multikine Phase III trial for head and neck cancer in Russia

CEL-SCI Corporation announced today that it has commenced its global Phase III clinical trial for Multikine®, the Company's flagship immunotherapy, in Russia at the State Budgetary Healthcare Institution of Sverdlovsk Region - Sverdlovsk Regional Oncology Center in Ekaterinburg, Russia.

20 May 2011

OPINION: U.S. administration must address humanitarian situation in Haiti

Reps. Yvette Clarke (D-N.Y.), Donald Payne (D-N.J.), and Frederica Wilson (D-Fla.) write in a Huffington Post opinion piece that the "increasing gravity of the situation" of internally displaced persons (IDP) camps in Haiti "requires an urgent response.

20 May 2011

Cell phones increase testosterone level, but decrease fertility in men

Men who have been diagnosed with poor sperm quality and who are trying to have children should limit their cell phone use. Researchers have found that while cell phone use appears to increase the level of testosterone circulating in the body, it may also lead to low sperm quality and a decrease in fertility.

20 May 2011

Breakthrough injectable gel for treating degeneration of the intervertebral disc

Chronic lower back pain is a major problem for society - behind only headaches as the most common neurological ailment - and is frequently caused by degeneration of the intervertebral disc.

From The University of Manchester 20 May 2011

Medical News

Complementary and alternative health practices show promise for management of pain

AIDS mortality in China drops by nearly two thirds since 2002 when country began free treatment program

Bayer, Onyx to present Nexavar-chemotherapy combination Phase 2b trial data in breast cancer at ASCO 2011

GIS discovery could help generate stem cells more efficiently for biomedical applications

African LGBT advocates warn against cutting multilateral aid to Uganda

Naltrexone improves clinical, inflammatory activity in Crohn's disease patients

Free, online tool to track exercise-induced asthma

9/11 Health fund administrator chosen

VBL to present positive VB-111 preclinical data in metastatic lung cancer at 14th ASGCT

Tornier announces launch of Porous Coated Affiniti Stem for shoulder joint replacement surgery

Study: Costs get in way of cancer patients refilling their prescriptions

HealthGrades identifies major flaws in hospital ratings study

Lilly's cixutumumab Phase II study results in five subtypes of sarcoma to be presented at 47th ASCO

Longer looks: Tough health care questions for GOP presidential contenders; Robotics help spike use of prostate treatment

Positive results from Onyx's carfilzomib Phase 2b 003-A1 study in relapsed and refractory multiple myeloma

ViroPharma commences VP 20621 Phase 2 study for prevention of recurrent Clostridium difficile infection

CEL-SCI initiates global Multikine Phase III trial for head and neck cancer in Russia

OPINION: U.S. administration must address humanitarian situation in Haiti

Cell phones increase testosterone level, but decrease fertility in men

Breakthrough injectable gel for treating degeneration of the intervertebral disc

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Latest News